Efficacy of Micro-Video Psychological Training Camp for Reducing Depression and Anxiety and Enhancing Resilience: A Randomized Controlled Trial

Wenqing Zhao, Wei Tang, Shuangyi Chen, Jiayu Yao, Jun Hu, Qing Zhou, Jing Tao, Rui Gao, Jie Zhang, Yanru Wu, Shanshan Su, Yuan Wang, Yousong Su, Yihua Peng, Yating Zhao, Qing Fan, Weibo Zhang, Wenhui Jiang, Jun Cai, Jianyin QiuResearch Square 2025 · DOI

This study presents a randomized controlled trial (RCT) evaluating the Micro-Video Psychological Training Camp (MVPTC), a fully automated, self-guided digital intervention designed to treat mild-to-moderate depression and anxiety. The results demonstrate that short, integrative video modules can significantly reduce symptoms and enhance psychological resilience, with benefits persisting for at least three months post-intervention.

TL;DR

The MVPTC is a scalable, fully automated digital intervention that uses micro-videos to deliver integrative psychotherapy. This RCT found that it significantly reduces depression and anxiety symptoms while boosting resilience and sleep quality, offering a promising solution for closing the global mental health treatment gap.

What Problem Does This Paper Address?

Mental health disorders like depression and anxiety are reaching record prevalence globally, yet a massive "treatment gap" remains. In many regions, including China, professional help is often inaccessible due to high costs, provider shortages, long wait times, and social stigma.

While internet-based Cognitive Behavioral Therapy (iCBT) has shown promise, many existing digital tools are either too text-heavy or lack the engagement needed for sustained use. The authors sought to bridge this gap by developing an automated, video-based "training camp" that integrates multiple therapeutic traditions (CBT, DBT, mindfulness, etc.) into a format that is easy to consume on a smartphone.

Methods

The researchers conducted a prospective, two-arm, unblinded RCT with 204 participants (aged 18–70) exhibiting mild-to-moderate symptoms.

  • The Intervention: The MVPTC group (n=97) received eight modules delivered via a WeChat applet every three days. These modules were "micro-videos" (averaging ~4 minutes) covering:
  • Psychoeducation on stress.
  • Emotional regulation (Dialectical Behavior Therapy - DBT).
  • Behavior activation (CBT).
  • Problem-solving (Solution-Focused Therapy).
  • Communication skills (Interpersonal Psychotherapy - IPT).
  • Cognitive reconstruction (CBT).
  • Mindfulness.
  • The Control: A waitlist control group (n=107) received no active instruction during the study period but was monitored for safety.
  • Evaluation: Assessments were conducted at baseline (T1), post-intervention (T2), 1-month follow-up (T3), and 3-month follow-up (T4) using a suite of validated psychological scales.

Datasets

As a clinical trial, the "dataset" consists of the longitudinal survey responses from the 204 participants. The primary instruments used for data collection were:

  • SDS & SAS: Self-Rating Depression and Anxiety Scales.
  • CD-RISC: Connor-Davidson Resilience Scale (measuring tenacity, strength, and optimism).
  • ISI: Insomnia Severity Index.
  • SCSQ: Simplified Coping Style Questionnaire.
  • PSSS: Perceived Social Support Scale.

Key Insights and Ideas

  • The Power of "Micro" Engagement: Participants actually spent more time watching the videos than their total duration (48 mins total viewing vs. 34 mins of content), suggesting they watched modules repeatedly to digest the material.
  • Integrative vs. Singular Approaches: Unlike many apps that stick strictly to CBT, MVPTC’s "integrative" approach—mixing DBT for regulation and IPT for social skills—seemed to provide a more holistic benefit, particularly for comorbid symptoms.
  • The "Early Disengagement Window": Attrition was highest early on; 66.7% of dropouts left after the first three sessions. This suggests that the first week is the "make or break" period for digital mental health interventions.
  • Predictors of Attrition: Younger age and lower baseline resilience were significant predictors of dropping out. This indicates that younger users or those with fewer internal resources might need more "human-in-the-loop" support or gamified incentives to stay engaged.

Key Results

The intervention group showed statistically significant improvements across nearly all metrics compared to the control group:

  • Depression (SDS): Large effect sizes were sustained through the 3-month follow-up (Cohen’s d = 0.87 at T2, 0.99 at T3, and 0.80 at T4).
  • Anxiety (SAS): Significant reductions were also observed (Cohen’s d = 0.71 at T2, 0.75 at T3, and 0.63 at T4).
  • Resilience & Sleep: Improvements in resilience (CD-RISC) and sleep quality (ISI) were not just immediate but grew or remained stable over the follow-up period (ISI Cohen’s d reached 1.08 at T3).
  • Acceptability: Participants rated the applet's simplicity and intelligibility highly (3.57/4.0), though they still expressed a general preference for the interactivity of face-to-face therapy.

Limitations and Future Work

The authors acknowledge several hurdles for real-world implementation:

  • High Attrition: A 36% dropout rate in the intervention group is common for self-guided apps but remains a challenge for efficacy.
  • Sample Bias: The participants were predominantly female, college-educated, and employed, which may limit how well these results generalize to more diverse or less tech-savvy populations.
  • Waitlist Control: Using a waitlist rather than an "active" control (like a sham app) means the researchers couldn't entirely rule out placebo effects or the benefit of simply being "enrolled" in a study.
  • Future Directions: The team suggests integrating AI-driven chatbots to provide the "feedback" and "companionship" that participants felt was missing, potentially reducing early-stage dropouts.

Summary updated

Abstract

<title>Abstract</title> <bold>Background:</bold> Anxiety disorders and depression are highly prevalent and comorbid, contributing to chronicity and symptom severity, yet treatment accessibility remains limited. Digital interventions serve as scalable adjuncts to traditional face-to-face therapies in resource-constrained settings. This study evaluated the feasibility, acceptability, and preliminary efficacy of the Micro-Video Psychological Training Camp (MVPTC), a fully automated digital intervention grounded in integrative psychotherapy principles and targeting mild-to-moderate depression/anxiety and multidimensional mental health. <bold>Methods:</bold> In this randomized controlled trial, 204 adults (aged 18–70) with mild-to-moderate symptoms were allocated to MVPTC (8 self-guided sessions, n=97) or waitlist control (n=107). Primary outcomes (Self-Rating Depression Scale [SDS], Self-Rating Anxiety Scale [SAS]) and secondary outcomes (Connor-Davidson Resilience Scale [CD-RISC]) were assessed at baseline (T1), post-intervention (T2), and 1-/3-month follow-ups (T3/T4). Exploratory outcomes included sleep quality (Insomnia Severity Index [ISI]), coping strategies (Simplified Coping Style Questionnaire [SCSQ]), and perceived social support (Perceived Social Support Scale [PSSS]). Feasibility (dropout/adherence) and acceptability (satisfaction ratings) were analyzed. <bold>Results:</bold> Participants (mean age 30.68±7.61 years; female : male=2:1) exhibited a 36.08% dropout rate in MVPTC versus 8.41% in controls. MVPTC significantly reduced depressive symptoms (SDS: Cohen’s d =0.87 at T2, 0.99 at T3, 0.80 at T4; all P&lt;0.01) and anxiety (SAS: Cohen’s d =0.71 at T2, 0.75 at T3, 0.63 at T4; P≤0.01), with sustained resilience improvements (CD-RISC: Cohen’s d =-0.97 at T3, -0.84 at T4; P&lt;0.01) and sleep quality gains (ISI: Cohen’s d =0.97–1.08; P≤0.01). Coping strategies improved transiently (SCSQ: Cohen’s d =-0.58 at T2, -0.53 at T3; P&lt;0.05), while social support showed no sustained group differences despite temporary family/friend support increases at T3 (Cohen’s d =-0.55 to -0.68; P&lt;0.05). This study indicates that participants found the intervention acceptable, with an average rating of 3.06±0.41 on a 0–4 scale (n=44). Notably, those in the MVPTC group reported high satisfaction across multiple domains. <bold>Conclusions:</bold> The MVPTC program is a promising intervention for mild to moderate depression and anxiety, significantly reducing symptoms while enhancing resilience, sleep quality, coping strategies, and social support, with core results effect sustained over a 3-month follow-up period. Its effectiveness and broad applicability highlight its potential for integration into routine mental health care and largescale implementation. Further research should prioritize enhancing adherence and motivation to ensure the long-term viability and accessibility of such interventions in real-world settings. <bold>Trial registration:</bold> Registered on Chinese Clinical Trial Registry (ChiCTR2100043725). Registered: February 27, 2021, http://www. chictr. org. cn/
BibTeX
@inproceedings{zhao2025efficacy,
  author = {Wenqing Zhao and Wei Tang and Shuangyi Chen and Jiayu Yao and Jun Hu and Qing Zhou and Jing Tao and Rui Gao and Jie Zhang and Yanru Wu and Shanshan Su and Yuan Wang and Yousong Su and Yihua Peng and Yating Zhao and Qing Fan and Weibo Zhang and Wenhui Jiang and Jun Cai and Jianyin Qiu},
  title = {{Efficacy of Micro-Video Psychological Training Camp for Reducing Depression and Anxiety and Enhancing Resilience: A Randomized Controlled Trial}},
  booktitle = {Research Square},
  year = {2025},
  doi = {10.21203/rs.3.rs-6717778/v1},
}
Figure